Overview

Controlled Hypotension During Functional Endoscopic Sinus Surgery

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
0
Participant gender:
All
Summary
It is very important to decrease the bleeding during functional endoscopic sinus surgery (FESS) in order to increase the visibility of the surgical site. Our primary goal was to investigate the effects of magnesium sulfate and dexmedetomidine used for controlled hypotension on visibility of surgical site.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
TC Erciyes University
Treatments:
Dexmedetomidine
Magnesium Sulfate
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

18 and 65 years scheduled for functional endoscopic sinus surgery

Exclusion Criteria:

- Patients with kidney, liver, hematological and neuromuscular diseases, diabetic
neuropathy, any known allergy history to studied agents.

- weight exceeding the ideal body weight more than 30%,

- Being treated with calcium channel blockers, non-steroidal anti-inflammatory drugs,
agents affecting neuromuscular blockage,and agents contraindicated for controlled
hypotension